Li et al. [36] designed a liposome conjugated with the tumor-homing peptide iRGD (c(CRGDKGPDC)), enabling enhanced tumor penetration and cell uptake for co-delivery of STING agonists and STAT3 inhibitors. This evidence concerns the gene STAT3 and neoplasm.